Laboratory for Molecular Diagnostics
Center for Nephrology and Metabolic Disorders
Moldiag Diseases Genes Support Contact

Phospholipase A2 receptor 1

The PLA2R1 gene encodes a secretory phospholipase. Autoantibodies angainst this protein were detected in membranous glomerulonephritis and polymorphisms in this gene show a strong correlation with idiopathic membranous nephropathy.

Genetests:

Clinic Method Carrier testing
Turnaround 5 days
Specimen type genomic DNA
Clinic Method Genomic sequencing of the entire coding region
Turnaround 25 days
Specimen type genomic DNA

Related Diseases:

Membranous nephropathy
HLA-DQA1
PLA2R1

References:

1.

Debiec H et al. (2014) Immunopathogenesis of membranous nephropathy: an update.

external link
2.

Ancian P et al. (1995) The human 180-kDa receptor for secretory phospholipases A2. Molecular cloning, identification of a secreted soluble form, expression, and chromosomal localization.

external link
3.

Beck LH et al. (2009) M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy.

external link
4.

Wuttke M et al. (2016) Insights into kidney diseases from genome-wide association studies.

external link
5.

Sinico RA et al. (2016) Immunology of membranous nephropathy: from animal models to humans.

external link
6.

Radice A et al. (2016) Clinical usefulness of autoantibodies to M-type phospholipase A2 receptor (PLA2R) for monitoring disease activity in idiopathic membranous nephropathy (IMN).

external link
7.

Li Y et al. (2016) Single-nucleotide polymorphisms in the PLA2R1 gene are associated with systemic lupus erythematosus and lupus nephritis in a Chinese Han population.

external link
8.

Hihara K et al. (2016) Anti-Phospholipase A2 Receptor (PLA2R) Antibody and Glomerular PLA2R Expression in Japanese Patients with Membranous Nephropathy.

external link
9.

Gentile G et al. (2016) Novel Biomarkers for Renal Diseases? None for the Moment (but One).

external link
10.

Francis JM et al. (2016) Membranous Nephropathy: A Journey From Bench to Bedside.

external link
11.

Ruggenenti P et al. (2015) Anti-Phospholipase A2 Receptor Antibody Titer Predicts Post-Rituximab Outcome of Membranous Nephropathy.

external link
12.

Ronco P et al. (2015) Pathophysiological advances in membranous nephropathy: time for a shift in patient's care.

external link
13.

Ronco P et al. (2015) Membranous nephropathy: A fairy tale for immunopathologists, nephrologists and patients.

external link
14.

Li ZQ et al. (2015) Efficacy and safety of tacrolimus vs. cyclophosphamide for idiopathic membranous nephropathy: A meta-analysis of Chinese adults.

external link
15.

Lai WL et al. (2015) Membranous nephropathy: a review on the pathogenesis, diagnosis, and treatment.

external link
16.

None (2015) Anti-phospholipase A2 Receptor Antibody and Immunosuppression in Membranous Nephropathy: More Evidence for Pathogenicity of Anti-phospholipase A2 Receptor Autoantibodies.

external link
17.

Smyth LJ et al. (2014) Genetic and epigenetic factors influencing chronic kidney disease.

external link
18.

Lv J et al. (2013) Interaction between PLA2R1 and HLA-DQA1 variants associates with anti-PLA2R antibodies and membranous nephropathy.

external link
19.

NCBI article

NCBI 22925 external link
20.

OMIM.ORG article

Omim 604939 external link
21.

Wikipedia article

Wikipedia EN (PLA2R1) external link
Update: Aug. 14, 2020
Copyright © 2005-2020 by Center for Nephrology and Metabolic Disorders, Dr. Mato Nagel, MD
Albert-Schweitzer-Ring 32, D-02943 Weißwasser, Germany, Tel.: +49-3576-287922, Fax: +49-3576-287944
Sitemap | Webmail | Disclaimer | Privacy Issues